ID Biomedical, Third Wave Settle Patent Infringement Case | GenomeWeb

NEW YORK, Oct 23 - Third Wave Technologies said Monday it would pay $4 million in cash and issue $6 million worth of its stock to ID Biomedical in exchange for the company’s commitment to drop a patent infringement lawsuit against Third Wave and its Invader line of products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.